Recent News

• 08.12.2025 - Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress
• 08.12.2025 - Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress
• 08.12.2025 - Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress
• 08.11.2025 - Veru Announces Selection of Novel Modified Release Oral Enobosarm Formulation for Chronic Weight Loss Management Following Pharmacokinetic Clinical Study
• 08.11.2025 - Veru Announces Selection of Novel Modified Release Oral Enobosarm Formulation for Chronic Weight Loss Management Following Pharmacokinetic Clinical Study
• 08.11.2025 - Veru Announces Selection of Novel Modified Release Oral Enobosarm Formulation for Chronic Weight Loss Management Following Pharmacokinetic Clinical Study
• 08.06.2025 - Veru Announces Reverse Stock Split
• 08.06.2025 - Veru Announces Reverse Stock Split
• 08.06.2025 - Veru Announces Reverse Stock Split
• 08.05.2025 - Veru to Report Fiscal 2025 Third Quarter Financial Results on August 12th

Recent Filings

• 07.25.2025 - 8-K Current report
• 07.16.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 07.15.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material